Matthew Ros Epizyme, Inc. (EPZM) insider trading activity

EPZM Quotes by TradingView

Matthew Ros is Officer of Epizyme, Inc.. Currently has a direct ownership of 111,313 shares of EPZM, which is worth approximately $0. The most recent transaction as insider was on Aug 16, 2021, when has been sold 28,125 shares (Common Stock, par value $0.0001) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 111K
0% 3M change
0% 12M change
Total Value Held $0

Matthew Ros Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 16 2021
BUY
Grant, award, or other acquisition
-
28,125 Added 20.17%
111,313 Common Stock, par valu...
Feb 04 2021
SELL
Open market or private sale
$10,022 $11.21 p/Share
894 Reduced 1.06%
83,188 Common Stock, par valu...
Feb 01 2021
BUY
Grant, award, or other acquisition
-
28,125 Added 25.07%
84,082 Common Stock
Jan 25 2021
SELL
Open market or private sale
$32,770 $11.41 p/Share
2,872 Reduced 4.88%
55,957 Common Stock, par valu...

Also insider at

COGT
Cogent Biosciences, Inc. Healthcare
MR

Matthew Ros

Officer
Cambridge, MA

Track Institutional and Insider Activities on EPZM

Follow Epizyme, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EPZM shares.

Notify only if

Insider Trading

Get notified when an Epizyme, Inc. insider buys or sells EPZM shares.

Notify only if

News

Receive news related to Epizyme, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EPZM